Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

527
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
527
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

395
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
395
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

13.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.8K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

367
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
367

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Oral Function and Underweight in Dental Outpatients Under Regular Maintenance: A Cross-Sectional Study.

Cureus·2026
Same author

Truck collisions attributed to falling asleep at the wheel in two commercial drivers prescribed oral appliance therapy for obstructive sleep apnea.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2023
Same author

Which treatments are effective in preventing motor vehicle accidents in patients with obstructive sleep apnea?

Sleep & breathing = Schlaf & Atmung·2023
Same author

Nocturnal Blood Pressure Fluctuations in Patients with Rapid Eye Movement-Related Obstructive Sleep Apnea.

Journal of clinical medicine·2021
Same author

Clinical guidance for peripartum management of patients with hereditary thrombophilia.

The journal of obstetrics and gynaecology research·2021
Same author

Comparative evaluation of reagents for measuring protein S activity: possibility of harmonization.

International journal of hematology·2021

Related Experiment Video

Updated: Feb 21, 2026

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.5K

Idiopathic thrombosis.

Hiroko Tsuda1

  • 1Graduate School of Health and Nutrition Sciences, Nakamura Gakuen University.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|October 6, 2017
PubMed
Summary
This summary is machine-generated.

Idiopathic thrombosis, caused by inherited antithrombin, protein C, or protein S deficiencies, is now recognized as an intractable disease. This designation improves medical expense aid for affected patients, enhancing care and research.

Keywords:
AntithrombinInherited thrombophiliaProtein CProtein S

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.8K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K

Related Experiment Videos

Last Updated: Feb 21, 2026

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.5K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.8K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K

Area of Science:

  • Hematology
  • Genetics
  • Public Health

Background:

  • Idiopathic thrombosis is linked to inherited thrombophilia, leading to early-onset severe thrombosis and recurrence.
  • Risk factors include immobility, dehydration, infection, surgery, injury, cancer, pregnancy, and estrogen use.
  • Inherited deficiencies of antithrombin (AT), protein C (PC), and protein S (PS) were previously classified as pediatric chronic diseases with limited financial aid after age 20.

Purpose of the Study:

  • To highlight the reclassification of idiopathic thrombosis due to inherited thrombophilia (AT, PC, PS deficiencies) as an "Intractable Disease" on April 1st, 2017.
  • To explain the implications of this reclassification for medical expense assistance.
  • To anticipate future advancements in research and clinical practice for idiopathic thrombosis.

Main Methods:

  • Review of disease classification and medical expense policies.
  • Analysis of the impact of reclassification on patient care.
  • Proposal for future research directions including clinical surveys and database construction.

Main Results:

  • Idiopathic thrombosis due to inherited AT, PC, and PS deficiencies was designated an "Intractable Disease" on April 1st, 2017.
  • This change made medical expense aid available, improving support for affected individuals.
  • The reclassification is expected to spur progress in research and clinical practice.

Conclusions:

  • The reclassification of idiopathic thrombosis as an intractable disease significantly improves the medical care system.
  • Enhanced financial aid facilitates better management and treatment of patients with inherited thrombophilia.
  • Future research and clinical surveys are crucial for building a comprehensive database and advancing patient outcomes.